Aptose Biosciences Inc. - APTO Net Assets per Single Share

Public company logo of Aptose Biosciences Inc. (APTO)

The visualization of book value per share on the GURU.Markets chart demonstrates the financial stability of Aptose Biosciences Inc. (APTO). A fabless production model utilizing external contractors eliminates operational downtime. The implementation of robotic cell analysis optimizes laboratory expenses. The strategy focuses on targeted leukemia therapy and attracting investment. The value of 0.00 expresses the latest metric level, determining the business's current margin of safety.

Aptose (APTO) - Accounting Value per Share from 07/04/2022 to 04/13/2025

Summary analytical data breakdowns for Aptose Biosciences Inc (APTO)

- price and consensus price forecast:
Stock Quotes Aptose|APTO - Analyst Forecast Prices
- market capitalization data:
Market Value Aptose Biosciences Inc.|APTO - Total Enterprise Value
- book capitalization data:
Book Value per Share Aptose Biosciences|APTO - Company Net Assets|Market Capitalization to Book Value Ratio aptose.com|APTO - Company Total Assets
- debt and liquidity data:
Debt to Equity Aptose Biosciences Inc.|APTO - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Aptose|APTO - Company Total Debt|Debts to Book Capitalization Aptose Biosciences Inc.
Analysis of all company metrics:aptose.com, APTO
Manufactured product of Aptose Biosciences Inc

Aptose Biosciences Inc. (APTO) focuses on developing innovative kinase inhibitors for the treatment of acute leukemias, a process that requires significant capital expenditures. Analyzing the book value per share allows for an assessment of net assets minus all liabilities, revealing the true intrinsic value of the business; steady growth in this metric confirms the quality of resources and minimizes the risk of overpaying for the asset.

Competitor analysis for Aptose Biosciences Inc.

Accounting Value per Share TG Therapeutics Corp TGTX|ACLX: Book Price of a Share|Net Assets per Single Share IRON|syndax.com (SNDX) - Net Asset Value per Share|Book Value per Share KURA|Accounting Value per Share ADC Therapeutics S.A.|Book Value per Share FHTX|Book Value per Share VOR (Vor Bio Inc.)|NKTX - Net Assets per Single Share|Equity per Share Coeptis Therapeutics Inc. COEP|ATNM: Book Value per Share|ESLA - Accounting Value per Share|Book Value per Share CASI|MRKR (Marker Therapeutics, Inc.) - Net Asset Value per Share|INAB - Net Assets per Single Share|Accounting Value of a Share Eterna Therapeutics Inc (ERNA)|GT Biopharma (GTBP) - Accounting Value per Share|Accounting Value of a Share Bio-Path Holdings Inc. (BPTH)|Book Value per Share MEI Pharma Corp MEIP|Vincerx Pharma Inc. - Net Assets per Single Share